has been cited by the following articles in journals that are participating in CrossRef's forward linking service: |
||
| Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline J Michael Kilby, Ha Youn Lee, J Darren Hazelwood, Anju Bansal, R Patterson Bucy, Michael S Saag, George M Shaw, Edward P Acosta, Victoria A Johnson, and Alan S Perelson AIDS (2008) 22: 957 Link to Article |
||
| Implications from the SIV model in understanding HIV neutralization Anna Laurén and Eva Maria Fenyö Future HIV Therapy (2008) 2: 47 Link to Article |
||
| Anti-HIV adaptive immunity: determinants for viral persistence Hiroyuki Yamamoto and Tetsuro Matano Reviews in Medical Virology (2008) 18: 293 Link to Article |
||
| Toward an AIDS Vaccine B. D. Walker and D. R. Burton Science (2008) 320: 760 Link to Article |
||
| Genetic and Immunologic Heterogeneity among Persons Who Control HIV Infection in the Absence of Therapy Florencia Pereyra, Marylyn M. Addo, Daniel E. Kaufmann, Yang Liu, Toshiyuki Miura, Almas Rathod, Brett Baker, Alicja Trocha, Rachel Rosenberg, and Elizabeth Mackey The Journal of Infectious Diseases (2008) 197: 563 Link to Article |
||
| Loss of HIV-1-specific T-cell responses associated with very rapid HIV-1 disease progression Hendrik Streeck, Becky Schweighardt, Heiko Jessen, Rachel L Allgaier, Terri Wrin, Eric W Stawiski, Arne B Jessen, Todd M Allen, Bruce D Walker, and Marcus Altfeld AIDS (2007) 21: 889???891 Link to Article |
||
| Biological and Genetic Evolution of HIV Type 1 in Two Siblings with Different Patterns of Disease Progression Chiara Ripamonti, Thomas Leitner, Anna Laurén, Ingrid Karlsson, Angela Pastore, Mariangela Cavarelli, Liselotte Antonsson, Anna Plebani, Eva Maria Fenyö, and Gabriella Scarlatti AIDS Research and Human Retroviruses (2007) 23: 1531 Link to Article |
||
| Influence of Strain, Dose of Virus, and Age at Inoculation on Subgroup J Avian Leukosis Virus Persistence, Antibody Response,
and Oncogenicity in Commercial Meat-Type Chickens Arun R. Pandiri, Willie M. Reed, Jody K. Mays, and Aly M. Fadly Avian Diseases (2007) 51: 725 Link to Article |
||
| HIV/AIDS Vaccines: 2007 H L Robinson Clinical Pharmacology & Therapeutics (2007) 82: 686 Link to Article |
||
| The impact of viral and host elements on HIV fitness and disease progression Kenneth R. Henry, Jan Weber, Miguel E. Quiñones-Mateu, and Eric J. Arts Current HIV/AIDS Reports (2007) 4: 36 Link to Article |
||
| HIV-1 vaccine development: Progress and prospects Anna R. Thorner and Dan H. Barouch Current Infectious Disease Reports (2007) 9: 71 Link to Article |
||
| Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination David C Montefiori, Lynn Morris, Guido Ferrari, and John R Mascola Current Opinion in HIV and AIDS (2007) 2: 169 Link to Article |
||
| Humoral immunity to HIV-1: neutralization and beyond M. Huber and A. Trkola Journal of Internal Medicine (2007) 262: 5 Link to Article |
||
| Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus
challenge Patricia Polacino, Brad Cleveland, Yongde Zhu, Jason T. Kimata, Julie Overbaugh, David Anderson, and Shiu-Lok Hu Journal of Medical Primatology (2007) 36: 254 Link to Article |
||
| Fc receptor but not complement binding is important in antibody protection against HIV Ann J. Hessell, Lars Hangartner, Meredith Hunter, Carin E. G. Havenith, Frank J. Beurskens, Joost M. Bakker, Caroline M. S. Lanigan, Gary Landucci, Donald N. Forthal, and Paul W. H. I. Parren Nature (2007) 449: 101 Link to Article |
||
| Virological and immunological bases for HIV-1 vaccine design Hiroyuki YAMAMOTO and Tetsuro MATANO Uirusu (2007) 57: 133 Link to Article |
||
| Group M-based HIV-1 Gag peptides are frequently targeted by T cells in chronically infected US and Zambian patients Anju Bansal, Ethan Gough, Doug Ritter, Craig Wilson, Joseph Mulenga, Susan Allen, and Paul A Goepfert AIDS (2006) 20: 353???360 Link to Article |
||
| Broad neutralization and complement-mediated lysis of HIV-1 by PEHRG214, a novel caprine anti-HIV-1 polyclonal antibody Erin E Verity, Lisa A Williams, Da??ed N Haddad, Vernon Choy, Chris O??Loughlin, Catherine Chatfield, Nitin K Saksena, Anthony Cunningham, Frank Gelder, and Dale A McPhee AIDS (2006) 20: 505???515 Link to Article |
||
| ERRATUM &NA; AIDS (2006) 20: 1093???1094 Link to Article |
||
| Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection Vincent Vieillard, Dominique Costagliola, Anne Simon, and Patrice Debr?? AIDS (2006) 20: 1795???1804 Link to Article |
||
| Continued Evolution in gp41 after Interruption of Enfuvirtide in Subjects with Advanced HIV Type 1 Disease Christina M.R. Kitchen, Jing Lu, Marc A. Suchard, Rebecca Hoh, Jeffrey N. Martin, Daniel R. Kuritzkes, and Steven G. Deeks AIDS Research and Human Retroviruses (2006) 22: 1260 Link to Article |
||
| The Effects of Early Antiretroviral Therapy and Its Discontinuation on the HIV-Specific Antibody Response M. Scott Killian, Philip J. Norris, Bhupat D. Rawal, Mila Lebedeva, Frederick M. Hecht, Jay A. Levy, and Michael P. Busch AIDS Research and Human Retroviruses (2006) 22: 640 Link to Article |
||
| Short Communication: Antiretroviral Therapy Does Not Induce HIV Type 1-Specific Neutralizing Activity against Autologous HIV Type 1 Isolates Claudia Devito, Bo Hejdeman, Jan Albert, Kristina Broliden, and Jorma Hinkula AIDS Research and Human Retroviruses (2006) 22: 908 Link to Article |
||
| High Incidence of Unusual Cysteine Variants in gp120 Envelope Proteins from Early HIV Type 1 Infections from a Phase 3 Vaccine
Efficacy Trial David V. Jobes, Melissa Daoust, Vivian Nguyen, Allan Padua, Suzanne Michele, Michael D. Lock, Allen Chen, Faruk Sinangil, and Phillip W. Berman AIDS Research and Human Retroviruses (2006) 22: 1014 Link to Article |
||
| HIV VACCINES Andrew J. McMichael Annual Review of Immunology (2006) 24: 227 Link to Article |
||
| Decimated or missing in action: CD4+ T cells as targets and effectors in the pathogenesis of primary HIV infection Anthony D. Kelleher and John J. Zaunders Current HIV/AIDS Reports (2006) 3: 5 Link to Article |
||
| Insights into neutralizing antibodies and HIV Envelope Nancy L Haigwood Current Opinion in HIV and AIDS (2006) 1: 301 Link to Article |
||
| Probing the possibilities for T-cell-based AIDS vaccines David A Garber and Mark B Feinberg Current Opinion in HIV and AIDS (2006) 1: 314 Link to Article |
||
| Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates Barton F Haynes and David C Montefiori Expert Review of Vaccines (2006) 5: 347 Link to Article |
||
| Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates Barton F Haynes and David C Montefiori Expert Review of Vaccines (2006) 5: 579 Link to Article |
||
| Antibody responses and virus escape: implications for HIV-1 vaccine and therapeutic design Georgia Tomaras, Xiaoying Shen, and Michael Greenberg Future Virology (2006) 1: 79 Link to Article |
||
| A Pharmacokinetic-Pharmacodynamic Model to Optimize the Phase IIa Development Program of Maraviroc Maria C. Rosario, Bill Poland, John Sullivan, Mike Westby, and Elna van der Ryst JAIDS Journal of Acquired Immune Deficiency Syndromes (2006) 42: 183 Link to Article |
||
| Neutralization kinetics of sensitive and resistant subtype B primary human immunodeficiency virus type 1 isolates David Davis, Helen Donners, Betty Willems, Michel Ntemgwa, Tine Vermoesen, Guido van der Groen, and Wouter Janssens Journal of Medical Virology (2006) 78: 864 Link to Article |
||
| Distribution and three-dimensional structure of AIDS virus envelope spikes Ping Zhu, Jun Liu, Julian Bess, Elena Chertova, Jeffrey D. Lifson, Henry Grisé, Gilad A. Ofek, Kenneth A. Taylor, and Kenneth H. Roux Nature (2006) 441: 847 Link to Article |
||
| Antiviral antibody responses: the two extremes of a wide spectrum Lars Hangartner, Rolf M. Zinkernagel, and Hans Hengartner Nature Reviews Immunology (2006) 6: 231 Link to Article |
||
| Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection George Makedonas and Michael R. Betts Springer Seminars in Immunopathology (2006) 28: 209 Link to Article |
||
| Combination DNA plus protein HIV vaccines Shan Lu Springer Seminars in Immunopathology (2006) 28: 255 Link to Article |
||
| The membrane-proximal external region of HIV-1 gp41: a vaccine target worth exploring Michael B Zwick AIDS (2005) 19: 1725???1737 Link to Article |
||
| Comparison of Whole Gene and Whole Virus Scrambled Antigen Approaches for DNA Prime and Fowlpox Virus Boost HIV Type 1 Vaccine
Regimens in Macaques Joko Pamungkas, Robert De Rose, Diah Iskandriati, Rachmitasari Noviana, Yasmina Paramastri, C. Jane Dale, Maryanne Shoobridge, C. Jill Medveczky, Ian A. Ramshaw, and Scott Thomson AIDS Research and Human Retroviruses (2005) 21: 292 Link to Article |
||
| Progress Toward an HIV Vaccine Norman L. Letvin Annual Review of Medicine (2005) 56: 213 Link to Article |
||
| Primary HIV-1 infection: Diagnosis, pathogenesis, and treatment Malini Soogoor and Eric S. Daar Current Infectious Disease Reports (2005) 7: 147 Link to Article |
||
| Development of an AIDS vaccine: A daunting epidemiological challenge Neal Nathanson and Bonnie J. Mathieson European Journal of Epidemiology (2005) 20: 123 Link to Article |
||
| HIV vaccines: brief review and discussion of future directions Karen S Slobod, Mattia Bonsignori, Scott A Brown, Xiaoyan Zhan, John Stambas, and Julia L Hurwitz Expert Review of Vaccines (2005) 4: 305 Link to Article |
||
| DermaVir: A Novel Topical Vaccine for HIV/AIDS Julianna Lisziewicz, Jeffrey Trocio, Lucia Whitman, Georg Varga, Jianqing Xu, Nyasha Bakare, Patrick Erbacher, Cecil Fox, Ruth Woodward, and Phil Markham Journal of Investigative Dermatology (2005) 124: 160 Link to Article |
||
| Infection with a molecularly cloned SIVsm virus elicits high titer homologous neutralizing antibodies with heterologous neutralizing
activity M. Mahalanabis, V.M. Hirsch, and N.L. Haigwood Journal of Medical Primatology (2005) 34: 253 Link to Article |
||
| Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis Stefan H E Kaufmann and Andrew J McMichael Nature Medicine (2005) 11: S33 Link to Article |
||
| Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies Alexandra Trkola, Herbert Kuster, Peter Rusert, Beda Joos, Marek Fischer, Christine Leemann, Amapola Manrique, Michael Huber, Manuela Rehr, and Annette Oxenius Nature Medicine (2005) 11: 615 Link to Article |
||
| Neutralizing antibodies take a swipe at HIV in vivo David C Montefiori Nature Medicine (2005) 11: 593 Link to Article |
||
| The host environment drives HIV-1 fitness Tim van Opijnen and Ben Berkhout Reviews in Medical Virology (2005) 15: 219 Link to Article |
||
| Genetic influences on HIV infection: implications for vaccine development Miranda Z. Smith and Stephen J. Kent Sexual Health (2005) 2: 53 Link to Article |
||
| HIV-1 virulence, fitness and replication capacity Eric S Daar Therapy (2005) 2: 131 Link to Article |
||
| HIV-1 virulence, fitness and replication capacity Eric S Daar Therapy (2005) 2: 131 Link to Article |
||
| Development of the antibody response in acute HIV-1 infection Marl??n MI Aasa-Chapman, Anna Hayman, Philippa Newton, David Cornforth, Ian Williams, Persephone Borrow, Peter Balfe, and ??ine McKnight AIDS (2004) 18: 371 Link to Article |
||
| Persistence of primary drug resistance among recently HIV-1 infected adults Jason D Barbour, Frederick M Hecht, Terri Wrin, Teri J Liegler, Clarissa A Ramstead, Michael P Busch, Mark R Segal, Christos J Petropoulos, and Robert M Grant AIDS (2004) 18: 1683 Link to Article |
||
| Seronegative infection and AIDS caused by an A2 subsubtype HIV-1 Ana R Cardoso, Cristina Gon??alves, Dulce Pascoalinho, Carla Gil, Ant??nio F Ferreira, In??s B??rtolo, and Nuno Taveira AIDS (2004) 18: 1071 Link to Article |
||
| Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory
analysis in the UK Register of HIV Seroconverters Krishnan Bhaskaran, Deenan Pillay, A Sarah Walker, Martin Fisher, David Hawkins, Richard Gilson, Ken McLean, and Kholoud Porter AIDS (2004) 18: 1471 Link to Article |
||
| Substitution of HIV Type-1 Non-B env Genes in C2, a Subtype B Cassette System, Results in Functional Chimeric Viruses Natalie N. Zheng and Rod S. Daniels AIDS Research and Human Retroviruses (2004) 20: 964 Link to Article |
||
| Current advances in HIV vaccines M. Patricia D’Souza, Mary Allen, Rebecca Sheets, and Margaret I. Johnston Current HIV/AIDS Reports (2004) 1: 18 Link to Article |
||
| Primary HIV infection Joanne Stekler and Ann C. Collier Current HIV/AIDS Reports (2004) 1: 68 Link to Article |
||
| HIV-1 entry inhibitors: closing the front door Brian Tomkowicz and Ronald G Collman Expert Opinion on Therapeutic Targets (2004) 8: 65 Link to Article |
||
| Requirement of diverse T-helper responses elicited by HIV vaccines: induction of highly targeted humoral and CTL responses Jonathan Luke Heeney Expert Review of Vaccines (2004) 3: S53 Link to Article |
||
| Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design Indresh K Srivastava, Jeffrey B Ulmer, and Susan W Barnett Expert Review of Vaccines (2004) 3: S33 Link to Article |
||
| Immunogen sequence: the fourth tier of AIDS vaccine design J I Mullins, David C Nickle, Laura Heath, Allen G Rodrigo, and Gerald H Learn Expert Review of Vaccines (2004) 3: S151 Link to Article |
||
| The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines S Staprans and Mark B Feinberg Expert Review of Vaccines (2004) 3: S5 Link to Article |
||
| Immunoprophylaxis to Prevent Mother-to-Child Transmission of HIV-1 Jeffrey T. Safrit, Ruth Ruprecht, Flavia Ferrantelli, Weidong Xu, Moiz Kitabwalla, Koen Van Rompay, Marta Marthas, Nancy Haigwood, John R. Mascola, and Katherine Luzuriaga JAIDS Journal of Acquired Immune Deficiency Syndromes (2004) 35: 169 Link to Article |
||
| Kinetics of protective antibodies are determined by the viral surface antigen Daniel D. Pinschewer, Mar Perez, Eswaraka Jeetendra, Thomas Bächi, Edit Horvath, Hans Hengartner, Michael A. Whitt, Juan Carlos de la Torre, and Rolf M. Zinkernagel Journal of Clinical Investigation (2004) 114: 988 Link to Article |
||
| Acute HIV revisited: new opportunities for treatment and prevention Christopher D. Pilcher, Joseph J. Eron, Shannon Galvin, Cynthia Gay, and Myron S. Cohen Journal of Clinical Investigation (2004) 113: 937 Link to Article |
||
| Progress on new vaccine strategies against chronic viral infections Jay A. Berzofsky, Jeffrey D. Ahlers, John Janik, John Morris, SangKon Oh, Masaki Terabe, and Igor M. Belyakov Journal of Clinical Investigation (2004) 114: 450 Link to Article |
||
| Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication David A. Garber, Guido Silvestri, Ashley P. Barry, Andrew Fedanov, Natalia Kozyr, Harold McClure, David C. Montefiori, Christian P. Larsen, John D. Altman, and Silvija I. Staprans Journal of Clinical Investigation (2004) 113: 836 Link to Article |
||
| Urgently needed: a filter for the HIV-1 vaccine pipeline John P Moore and Dennis R Burton Nature Medicine (2004) 10: 769 Link to Article |
||
| Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know Giuseppe Pantaleo and Richard A Koup Nature Medicine (2004) 10: 806 Link to Article |
||
| Randomized, Controlled Trial of Therapy Interruption in Chronic HIV-1 Infection Emmanouil Papasavvas, Jay R. Kostman, Karam Mounzer, Robert M. Grant, Robert Gross, Cele Gallo, Livio Azzoni, Andrea Foulkes, Brian Thiel, and Maxwell Pistilli PLoS Medicine (2004) 1: e64 Link to Article |
||
| Role of neutralizing antibodies in HIV infection Nancy L Haigwood and Leonidas Stamatatos AIDS (2003) 17: 67 Link to Article |
||
| Present status of human HIV vaccine development Sandra A Calarota and David B Weiner AIDS (2003) 17: S73 Link to Article |
||
| Progress in the development of an HIV vaccine Edmund C Tramont and Margaret I Johnston Expert Opinion on Emerging Drugs (2003) 8: 37 Link to Article |
||